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Summary Trends in mortality for main cancer sites in France between 1950 and 1985 are presented by sex. In
the population aged 35-65, where long term trends can most reliably be assessed, an overall 1.1% mean
annual increase is observed for males and a 0.6% mean annual decrease is observed for females. For males,
this increase in total cancer mortality is mostly due to the sites associated with tobacco and alcohol. The
important increase for lung cancer, and lesser increases for bladder, pancreas and kidney cancers are related to
the increase in tobacco consumption from 4.7 g per adult per day in 1950 to 6.3 g in 1976. For cancer sites
associated with alcohol and tobacco, namely oesophagus, pharynx, larynx, tongue and mouth, mortality is
increasing similarly for males and for females, although these cancers are much less frequent among females.
For females, the overall moderate decrease is mostly due to the decrease in cervix and stomach cancer
mortality, uncompensated by the observed increase in breast cancer; there is no marked increase in lung cancer
mortality for women, contrary to what is observed in other Western countries.
In France, as in most developed countries, cancer is the
second most common cause of death after cardiovascular
diseases. In 1985, 24% of all deaths were caused by cancers,
28% of male deaths and 20% of female deaths. Cardiovas-
cular diseases caused 37% of all deaths, 33% for males and
41% for females.
Between age 35 and 64, cancer is by far the most common
cause of death, 39% of all deaths (37% for males and 42%
for females). Cardiovascular deaths represent 21% of all
deaths, 23% for males, 18% for females.
The variations in cancer mortality with time are very large
in many countries and represent important clues for cancer
aetiology. France is interesting because of the evolution
observed in alcohol and tobacco consumption. Tobacco con-
sumption used to be low, particularly for women, but has
been increasing in the recent past. Alcohol consumption used
to be exceptionally high, but has been decreasing regularly
over the last 35 years.
The study of long term trends in cancer can be based only
on national mortality statistics, since there is no national
cancer registry in France; the regional registries cover less
than 10% of the 55 million population, and do not have data
for years prior to 1975.
We present here a summary of the main trends in cancer
mortality observed in France between 1950 and 1985. Exten-
sive tabulations can be found in Hill et al. (1989).
Materials and methods
National death statistics based on death certificates are pub-
lished each year in France by cause, sex, and age in 5-year
age-groups, the most recent publication being (Lion et al.,
1988). The quality of death certification has improved with
time, 18% of all death certificates did not specify any cause
in 1952, versus 6% in 1985. This proportion depends on age,
being in 1952, 11% before age 35, 9% between age 35 and
64, and 23% after age 64; in 1985 these proportions were
15%, 5% and 6%, respectively.
Estimates of the size of the population, by sex and age are
published each year by the Institut National de la Statistique
et des Etudes Economiques (INSEE).
Four revisions of the International Classification of Di-
seases (ICD) have been in use between 1950 and 1985
(ICD 6, 7, 8 and 9), there were some modifications in the
coding of cancer sites during this period. The correspondence
between the codes can be found in Hill et al. (1989). The
major differences are between ICD 8 and 9. The conversion
rules recommended by Percy (1981) have been used. Mor-
tality rates have been standardised on the standard European
population (Waterhouse et al., 1976).
Standard rates are truncated between ages 35 and 64.
Standardised sex mortality ratios are defined as the ratio of
male to female European standardised rates. Mean per cent
variations are computed between 1950-54 and 1981-85 as
the difference between the logarithms of the rates divided by
31.
Results and discussion
Figures 1 and 2 show the trends for the main sites of cancer,
for each sex, for the population aged 35-64. Table I gives
the mean per cent variations between 1950-54 and 1981-85.
Improvements in diagnostic procedures explain probably
most of the increases observed for brain and nerves, and for
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ovary for women over age 50. The decrease observed for
bone tumours is at least partly caused by a better differential
diagnosis between primary and metastatic tumours. The
decrease in the number of deaths due to Hodgkin's disease is
attributable to treatment.
Tobacco and alcohol are, in France as in many countries,
major risk factors for cancer. Tobacco consumption in-
creased from 4.7 g per adult (15 years or over) per day in
1950 to 6.3 g in 1976 (Figure 3). This explains the observed
increase for a number of cancer sites for males, very impor-
tant for lung cancer (85% attributable to tobacco), and less
for bladder, pancreas and kidney. The consequences of
tobacco smoking on lung cancer mortality are just beginning
to be detectable in the female population. It is only in the
cohorts born after 1960 that the percentage of smokers is the
same for men and for women. In older cohorts, the propor-
tion of smokers is much smaller among women than among
men, and these female smokers smokeless, inhale less, have
been smokers for a shorter time than male smokers; they also
smoke more often lighter cigarettes or cigarettes with filter-
tip (Hirsch et al., 1987).
Cancer of the tongue, mouth (floor and other parts),
pharynx, oesophagus and larynx are related both to alcohol
and tobacco consumption. These two factors act synergis-
tically, and their relative importance depends on the site.
While the consumption of tobacco was increasing, the con-
sumption of alcohol was regularly decreasing from 25 litres
of pure alcohol per adult (15 years or over) in 1950 to 17.5
litres in 1985 (Figure 3). This decrease is due to a decrease in
the consumption of ordinary wine, uncompensated by the
increase in the consumption of beer and in wine of higher
quality. Probably three-quarters of the cancers of the tongue,
mouth, pharynx, oesophagus and larynx are attributable to
tobacco, and the fraction attributable to alcohol is of the
same order of magnitude. These two fractions cannot be
added because most of the patients -dying from these cancers
had been exposed to both factors. Reducing the exposure to
any of these factors would reduce the risks noticeably.
Figures 4 and 5 show the trends for some tobacco and
alcohol related sites, on a logarithmic scale, for males and for
females aged 35-64. Although these cancers are much less
frequent among females than among males, the similarity of
the trends for males and for females is quite striking for all
sites except for lung. Head and neck cancers may appear
after a shorter exposure to tobacco than lung cancer, partic-
ularly when tobacco is associated with alcohol. Inhaling
tobacco smoke increases the risk of lung cancer but possibly
does not modify the risk of tobacco related head and neck
cancer.
Alcohol and hepatitis B viral infection are important risk
factors for liver cancer in France, where the effects of
aflatoxins are negligible. Following the decrease of alcohol
consumption since 1950, one could expect a decrease or at
least stability in liver cancer mortality rates, as is observed
Table I Average annual variation for cancer death rates, all ages, and age 35-64 (rates per 100,000, standardised on the standard European
population)
Average annual variation (%)
All ages Age 35-64
Site ofcancer Males Females Males Females
Lip -2.2 -2.9 -1.5 -2.8
Tongue 1.8 1.3 2.4 2.3
Salivary glands 0.8 0.3 0.7 1.0
Mouth (floor and other parts) 4.0 3.6 5.0 5.3
Pharynx 3.7 2.6 4.1 4.1
Oesophagus' 0.6 -0.4 0.8 1.1
Stomach' -2.8 -3.6 -3.6 -4.5
Colon, rectum and small intestine' 0.6 - 0.6 0.0 -0.9
Liver (primary) & intra-hepatic bile ductsb 8.7 4.0 8.3 3.7
Liver specified as primary or unspecified." 0.8 -4.8 0.9 -5.1
Liver unspecified primary or notc - 3.2 - 6.8 - 3.7 -7.9
Liver secondary and unspecified.d - 1.2 - 3.8 - 1.4 - 4.4
Gallbladder and extra-hepatic bile ductsb 2.3 1.4 1.3 0.5 Pancreas 2.4 1.5 2.1 0.8 Peritoneum and digestive unspecified 1.0 - 0.4 1.1 -1.1 Larynxa 0.4 - 0.9 0.3 0.4
Trachea, bronchus, lung and pleuraT 4.2 1.2 3.3 0.5 Respiratory other and unspecified 5.5 0.5 6.0 0.8
Bone -1.7 -3.3 -1.7 -4.4 Soft tissue 6.4 6.1 5.1 5.8 Malignant melanoma of the skin 8.4 8.1 8.4 7.7 Skin, excluding melanoma -3.9 - 5.4 - 3.7 - 3.6
Breasta 0.1 1.2 -0.2 1.2
Uterus (cervix and corpus)a - - 1.8 - -2.5 Ovary 2.8 - 2.0 Genital females other and unspecified - 0.5 - - 0.8 ProstateT 1.8 - 0.6
Testis 0.4 - 0.3
Genital males other and unspecified - 1.0 - - 0.7
Bladder 2.9 0.8 2.1 -0.6 Kidney 2.8 1.5 2.4 1.0 Eye 2.0 1.3 2.7 2.6
Brain or nervesa 4.7 4.7 4.2 4.0 Thyroid 1.5 0.2 0.8 -0.3 Other, secondary except liver' 0.3 - 2.0 0.4 - 2.6 Other, ill defined and unspecifiedc 2.4 - 1.1 2.9 - 2.6
Hodgkin's disease -1.9 -2.5 - 2.1 -2.7
Other neoplasms of lymphoid tissue 3.4 3.7 2.4 2.7
Multiple myeloma 8.9 8.8 5.8 5.8 Leukaemiasa 1.9 1.5 0.6 0.5
All cancersa 1.2 -0.4 1.1 -0.6
Unless otherwise specified, the variations were computed between 1952 -56 and 1981 -85.aVariation between 1950-54 and 1981-85; bVariation between 1958-62 and 1981-85; c Variation between 1968-72 and 1981-85; 'Variation between 1952-56 and 1974-78.CANCER MORTALITY IN FRANCE 589
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Figure 2 Trends in cancer mortality, French females, age 35-64.
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and alcohol consumption, France
for cirrhosis mortality; instead a striking increase is observed,
particularly for males. However, this increase could be ex-
plained entirely by an increase in the diagnosis of hepatocar-
cinomas in cirrhotic patients, from 0% in 1977 to 6% in
1985.
Stomach cancer, mortality decreased regularly both for
men and for women. This decrease has been observed in
most developed countries and is attributed to the generalisa-
tion of refrigeration as a way to conserve food, thereby
reducing the consumption of food items with a high content
in salt and nitrates.
Colorectal cancer mortality is relatively constant for males
and decreases slightly for females. Ongoing prevention stud-
ies may lead to more precise identification of suspected
aetiologic factors, either protective (vitamin A, a diet with a
high fibre content, etc.) or detrimental (fat).
The increase in breast cancer mortality is very important
for women aged 35-64. In 1985, breast cancer caused about
three times more deaths than colorectal cancer which is the
second most common cause of death by cancer in females.
Breast cancer is now almost as frequent in France as in the
USA, which is very different from the situation in the 1950s.
The decrease observed for cancer of the uterus is probably
due to a decrease of mortality from cancer of the cervix
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Figure 4 Mortality trends for tobacco and/or alcohol-related
cancer sites, French males, age 35-64, logarithmic scale.
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Figure 5 Mortality trends for tobacco and/or alcohol-related
cancer sites, French females, age 35-64, logarithmic scale.590 C. HILL et al.
rather than from the uterine corpus. This decrease is prob-
ably related both to improvements in hygiene and to screen-
ing leading to treatment of precancerous lesions and earlier
treatment of cancers.
The general trends in cancer mortality observed in France
are quite similar to what is observed in other Western coun-
tries: for males, one observes an overall increase, mostly due
to respiratory and upper digestive tract cancers, and a
decrease for stomach cancer; for females, one observes an
overall moderate decrease, mostly due to cervix and stomach
cancer, and an increase in breast cancer mortality. The par-
ticularities of cancer mortality in France compared to other
countries are the low lung cancer mortality rate in females
and the high mortality for mouth, pharynx and oesophagus.
References
HILL, C., BENHAMOU, E., DOYON, F. & FLAMANT, R. (1989). Evolu-
tion de la mortalite par cancer en France entre 1950 et 1985.
INSERM: Paris.
HIRSCH, A., HILL, C., FROSSART, M., TASSIN, J.P. & PECHABRIER,
M. (1987). Lutter contre le tabagisme. La documentation fran-
qaise: Paris.
LION, L., HATrrON, F., MAGUIN, P. & MAUJOL, L. (1988). Statisti-
ques medicales des causes de deces 1985. INSERM: Paris.
PERCY, C.L. (1981). Conversion of neoplasm section, 8th revision of
international classification of diseases (1965) to 9th revision of
international classification of diseases (1975). USDHSS: Beth-
esda, Md.
WATERHOUSE, J., MUIR, C., CORREA, J. & POWELL, J. (eds) (1976).
Cancer Incidence in Five Continents, Vol III. IARC: Lyon.